Cutler Group’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,000
Closed -$1K 4411
2022
Q3
$1K Buy
+1,000
New +$5.14K ﹤0.01% 4433
2022
Q1
Sell
-21,600
Closed -$11K 5325
2021
Q4
$11K Buy
21,600
+5,300
+33% +$50.4K ﹤0.01% 3600
2021
Q3
$10K Buy
16,300
+8,400
+106% +$73.4K ﹤0.01% 3902
2021
Q2
$4K Buy
7,900
+6,000
+316% +$59.2K ﹤0.01% 4548
2021
Q1
$7K Buy
+1,900
New +$26.4K ﹤0.01% 4078

Other funds holding SRTA

Cutler Group's SRTA Position: Q1 2023 in Review

Cutler Group sold out of Strata Critical Medical Inc (SRTA) in Q1 2023, closing a stake of 470 shares — an estimated $1.92K sold.

Cutler Group first reported a position in SRTA in Q1 2021 and held it in 7 quarters. The position peaked at $77K in Q1 2021. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.

  • Cutler Group reported no remaining Strata Critical Medical Inc position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 470 Strata Critical Medical Inc shares in Q1 2023, an estimated $1.92K.
  • Cutler Group first reported a position in Strata Critical Medical Inc in Q1 2021 and held it in 7 quarters.
  • Cutler Group's Strata Critical Medical Inc position peaked at $77K in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.